Cencora Inc. stock outperforms competitors despite losses on the day
Shares of Cencora Inc. COR shed 1.28% to $243.59 Wednesday, on what proved to be an all-around grim trading session for the ...
To Pay Down Debt, Walgreens Sells More Cencora Shares For $300 Million
Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million in the latest effort to pay ...
Q2 Earnings Estimate for Cencora Issued By Leerink Partnrs
Leerink Partnrs dropped their Q2 2025 EPS estimates for Cencora in a report released on Wednesday, February 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $4.08 per ...
Walgreens sells more shares in Cencora; cuts stake to 6%
U.S. drugstore chain Walgreens Boots Alliance said on Thursday it has sold more shares in drug distributor Cencora for ...
Walgreens Boots Alliance sells $314 million in Cencora stock
Walgreens Boots Alliance, Inc. (NASDAQ:WBA), through its subsidiary Walgreens Boots Alliance Holdings LLC, recently reported significant stock transactions involving Cencora, Inc. (NYSE:COR), a ...
Cencora expands drug shortages mitigation program
Cencora (COR) has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation ...
Cencora raises 2025 profit forecast on specialty drug demand
Drug distributor Cencora raised its fiscal 2025 profit forecast on Wednesday, driven by robust demand for expensive specialty medicines.
Possible Bearish Signals With Cencora Insiders Disposing Stock
Over the past year, many Cencora, Inc. ( NYSE:COR ) insiders sold a significant stake in the company which may ...
Cencora Inc. stock underperforms Thursday when compared to competitors
Shares of Cencora Inc. COR slid 2.82% to $246.13 Thursday, on what proved to be an all-around mixed trading session for the ...
Cencora Q1 Earnings: Revenue And EPS Beat On Strong Push From Obesity Drugs, Specialty Medicines
Cencora, Inc (NYSE:COR) reported first-quarter 2025 sales increased 12.8% to $81.5 billion, beating the consensus of $78.38 ...
Cencora price target raised to $301 from $287 at Leerink
Leerink analyst Michael Cherny raised the firm’s price target on Cencora (COR) to $301 from $287 and keeps an Outperform rating on the shares ...
Reuters6d
Walgreens sells more shares in Cencora; cuts stake to 6%
Feb 6 (Reuters) - U.S. drugstore chain Walgreens Boots Alliance (WBA.O), opens new tab said on Thursday it has sold more shares in drug distributor Cencora (COR.N), opens new tab for proceeds of ...